Lung cancerKinase InhibitorsTabrecta coupons

Tabrecta Coupons & Savings Card – Discount Prices from $12047.79

Capmatinib, marketed as Tabrecta, is an oral medication specifically designed to treat non-small cell lung cancer (NSCLC) that has metastasized, particularly in cases involving alterations in the MET gene. This medication functions by inhibiting the growth and spread of cancer cells, as it belongs to the class of drugs known as kinase inhibitors. Patients benefit from the convenience of taking Tabrecta orally twice a day without the need for additional medications. However, it is important to monitor for possible side effects such as liver and pancreas issues, which necessitates regular blood tests. Other potential side effects include swelling of the hands and feet, muscle or joint pain, and nausea. Always consult a healthcare professional such as a doctor, nurse, or pharmacist before starting this medication for personalized advice and monitoring.
FAQs

My prescription

Edit

150MG, Tabrecta (56 Tablets)

Select pharmacy

See local prices

Albertsons logo

Albertsons

$12,047.79

COUPON PRICE
Walgreens logo

Walgreens

$12,101.79

COUPON PRICE
Walmart logo

Walmart

$12,117.29

COUPON PRICE

Tabrecta savings card

Show this card to your pharmacist
albertsons logo

Albertsons

$12,047.79

BIN

ID

PCN

GRP

019876

LH6D60AE06

CHIPPO

LHX

Powered by

This coupon is not insurance

Related kinase inhibitors prescriptions

Rezurock
coupons from$19,660.77Save 70%
Cabometyx
coupons from$27,965.12Save 71%
Rydapt
coupons from$489.18Save 98%
Imbruvica
coupons from$16,399.63Save 75%
Sprycel
coupons from$805.87Save 96%
Zortress
coupons from$271.40Save -10%
Bosulif
coupons from$4,012.66Save 78%
Afinitor
coupons from$384.00Save 98%

More prescriptions for lung cancer

Xgeva
coupons from$3,418.91Save 73%
Gilotrif
coupons from$12,420.47Save 14%
Krazati
coupons from$23,789.49Save 14%
Bevacizumab
coupons from$54.28Save 76%
Xalkori
coupons from$24,541.84Save 14%
Erlotinib
coupons from$99.00Save 93%
Tagrisso
coupons from$19,311.04Save 14%
Lorbrena
coupons from$23,153.12Save 14%

Related kinase inhibitors prescriptions

Rezurock Save 70%coupons from $19,660.77
Cabometyx Save 71%coupons from $27,965.12
Rydapt Save 98%coupons from $489.18
Imbruvica Save 75%coupons from $16,399.63
Sprycel Save 96%coupons from $805.87
Zortress Save -10%coupons from $271.40
Bosulif Save 78%coupons from $4,012.66
Afinitor Save 98%coupons from $384.00

More prescriptions for lung cancer

Xgeva Save 73%coupons from $3,418.91
Gilotrif Save 14%coupons from $12,420.47
Krazati Save 14%coupons from $23,789.49
Bevacizumab Save 76%coupons from $54.28
Xalkori Save 14%coupons from $24,541.84
Erlotinib Save 93%coupons from $99.00
Tagrisso Save 14%coupons from $19,311.04
Lorbrena Save 14%coupons from $23,153.12

Price history for Tabrecta

56 Tablets, 150MG

Average retail price for Tabrecta

Average SaveHealth price for Tabrecta

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Tabrecta dosage forms

Use our Tabrecta 150MG coupon with prices from $12,047.79 for 56 Tablets. You can also use our Tabrecta 200MG coupon with prices from $12,047.79 for 56 Tablets.
DosageQuantityPrice fromPer unit
150MG56 Tablets$12,047.79$215.14
200MG56 Tablets$12,047.79$215.14
Tabrecta FAQs
What is the drug Tabrecta used for?

Tabrecta is used for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) that have a mutation leading to mesenchymal-epithelial transition (MET) exon 14 skipping. It is specifically indicated for patients whose tumors have this genetic alteration.

The success rate of Tabrecta (capmatinib) can vary depending on several factors, including the specific characteristics of the patient's cancer. In clinical trials, Tabrecta has shown an overall response rate of approximately 68% in patients with non-small cell lung cancer (NSCLC) who have MET exon 14 skipping mutations. It is important for patients to discuss their individual case with their healthcare provider to understand how effective Tabrecta might be for them.

The time it takes for Tabrecta (capmatinib) to work can vary depending on the individual and the specific condition being treated. Some patients may begin to notice improvements within a few weeks, while for others, it may take longer. It is important for patients to follow their healthcare provider's instructions and attend regular follow-up appointments to monitor the effectiveness of the treatment.

Another name for Tabrecta is capmatinib.

Tabrecta (capmatinib) is considered effective for treating adults with metastatic non-small cell lung cancer (NSCLC) that have a mutation leading to mesenchymal-epithelial transition (MET) exon 14 skipping. Its effectiveness is based on clinical trials that demonstrated a significant response rate in patients with this specific genetic mutation. However, the effectiveness can vary among individuals, and it is important for patients to discuss their specific case with their healthcare provider.

Related Drugs